---
title: "OSTX: Net loss increased to $19.0 million amid rising R&D costs and ongoing liquidity challenges"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295977206.md"
description: "Net loss widened to $19.0 million for the first half of 2026, driven by higher R&D expenses as clinical and regulatory activities accelerated. Cash resources remain limited, raising substantial doubt about ongoing operations, though $4.7 million was raised in August with more financing available.Original document: OS Therapies Incorporated [OSTX] SEC 10-Q Quarterly Report — Aug. 14 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-14T21:03:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295977206.md)
  - [en](https://longbridge.com/en/news/295977206.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295977206.md)
generator: "portal-rs"
---

# OSTX: Net loss increased to $19.0 million amid rising R&D costs and ongoing liquidity challenges

Net loss widened to $19.0 million for the first half of 2026, driven by higher R&D expenses as clinical and regulatory activities accelerated. Cash resources remain limited, raising substantial doubt about ongoing operations, though $4.7 million was raised in August with more financing available.

Original document: OS Therapies Incorporated \[OSTX\] SEC 10-Q Quarterly Report — Aug. 14 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [OSTX.US](https://longbridge.com/en/quote/OSTX.US.md)

## Related News & Research

- [OS Therapies management to attend H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/297776547.md)
- [OS Therapies Provides OST-HER2 Metastatic Osteosarcoma Program Update and Announces Upcoming Conference Attendance | OSTX Stock News](https://longbridge.com/en/news/297777149.md)
- [Iomart publishes 2026 annual report](https://longbridge.com/en/news/297739507.md)
- [Maris-Tech to showcase UAV video, AI modules at AUSA 2026](https://longbridge.com/en/news/298127031.md)
- [Pininfarina announces availability of H1 2026 interim financial report](https://longbridge.com/en/news/298044460.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**